Drug Development
Pivotal phase III trials of Japanese encephalitis vaccine begin
Published in Vaccine Weekly, October 12th, 2005
Japanese encephalitis (JE) is a mosquito-borne flaviviral infection and the leading cause of viral encephalitis in Asia.
The infection is a major health problem throughout Asia where 3 billion people live in JE-endemic areas. A safe and efficacious traveler vaccine for tourists visiting Asian countries will meet a high unaddressed medical need. The global phase III program consists of a series of immunogenicity and safety trials, and will enroll more than 4900 subjects. Furthermore, a one time vaccination schedule...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2005-10-12)
More Articles from Vaccine Weekly
- Hepatitis C Vaccine Development
Hepatitis C virus-host interactions examined - Myeloma Vaccine Development
Tumor antigen immunization of stem cell transplant donors reported - Rotavirus Vaccine Development
Human rotavirus-bovine rotavirus reassortant vaccine developed - Rotavirus Vaccine Development
Pentavalent rotavirus vaccine against gastroenteritis developed - Vaccine Development
Killed but active microbes proposed for new vaccine paradigm - Anthrax Vaccine Development
Antibody patterns in anthrax vaccinees reported - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
